SCHEMBL6537900

SCHEMBL6537900

O=C(Nc1cccc2c(Oc3ccc(-n4ccnc4)cc3)ccnc12)c1c(Cl)cccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ICAM1 P05362 2/20 0.44
SELE P16581 2/20 0.44
VCAM1 P19320 2/20 0.44
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
LMNA P02545 3/20 0.41
MAPT P10636 3/20 0.41
KDR P35968 3/20 0.40
CD38 P28907 1/20 0.40
PDGFRA P16234 1/20 0.40
GPR142 Q7Z601 1/20 0.40
PORCN Q9H237 1/20 0.39
JAK2 O60674 1/20 0.39
JAK1 P23458 1/20 0.39
TYK2 P29597 1/20 0.39
MAPK1 P28482 1/20 0.39
ALDH1A1 P00352 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8475365 0.83 JAK2 (0.47) CYP3A4LMNAMAPTKDRPDGFRA
SCHEMBL6537488 0.81 CYP3A4 (0.48) CYP3A4CYP2D6CYP1A2CYP2C9CYP2C19
SCHEMBL6537597 0.76 HSD17B10 (0.55) LMNAMAPTKDRPDGFRAJAK2
SCHEMBL6537462 0.75 TYK2 (0.49) CYP3A4LMNAMAPTKDRJAK2
SCHEMBL8474859 0.74 CYP3A4 (0.52) CYP3A4CYP2D6CYP1A2CYP2C9CYP2C19
SCHEMBL6537504 0.74 CYP3A4 (0.47) CYP3A4CYP2D6CYP1A2CYP2C9CYP2C19
SCHEMBL6537346 0.74 CYP3A4 (0.47) CYP3A4CYP2D6CYP1A2CYP2C9CYP2C19
SCHEMBL6537494 0.74 CD38 (0.46) CYP3A4CYP2D6CYP1A2CYP2C9CYP2C19
SCHEMBL6537740 0.74 CYP3A4 (0.46) CYP3A4CYP2D6CYP1A2CYP2C9CYP2C19
SCHEMBL6538283 0.74 CYP3A4 (0.46) CYP3A4CYP2D6CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed